title: [Porokeratosis in a patient with dermatomyositis].
abstract: There are several reports of porokeratosis in the context of immmunosuppressive diseases. These mainly include organ transplant, HIV infection, lymphomas and some inflammatory and autoimmune diseases commonly treated with immunosuppresive drugs or chemotherapy. Disseminated superficial actinic porokeratosis is the clinical variant of porokeratosis that most frequently develops in immunosuppressive states. We report a case of porokeratosis in a woman with dermatomyositis.
authors.affiliation: Servicio de Dermatología, Complejo Hospitalario Arquitecto Marcide-Novoa Santos, Ferrol, La Coruña, Spain. benims@hotmail.com
authors.forename: B
authors.initials: B
authors.lastname: Monteagudo-Sánchez
authors.forename: M
authors.initials: M
authors.lastname: Ginarte
authors.forename: C
authors.initials: C
authors.lastname: Durana
authors.forename: J
authors.initials: J
authors.lastname: Labandeira
authors.forename: C
authors.initials: C
authors.lastname: de las Heras
authors.forename: J M
authors.initials: JM
authors.lastname: Cacharrón
mesh_terms: D000368:Aged; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D017499:Porokeratosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate